as on November 7, 2025 at 1:39 am IST
Day's Low
Day's High
1.13%
Downside
0.72%
Upside
52 Week's Low
52 Week's High
24.90%
Downside
12.24%
Upside
Check Abbvie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$381.4B
EPS (TTM)
10.644
Dividend Yield
3.10%
Quarterly Earnings Growth YOY
-0.89%
PE Ratio (TTM)
161.11
Industry PE ratio
18.176666666666666
PEG Ratio
0.4252
EBITDA
28.5B
Revenue (TTM)
59.6B
Profit Margin
4.00%
Return On Equity TTM
112.85%
Track how Abbvie Inc P/E has moved over time to understand its valuation trends.
Abbvie Inc in the last 5 years
Lowest (9.14x)
December 31, 2020
Industry (18.18x)
November 6, 2025
Today (161.11x)
November 6, 2025
Highest (18.93x)
March 31, 2025
Today’s Price to Earnings Ratio: 161.11x
Compare market cap, revenue, PE, and other key metrics of Abbvie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $381.4B | 133.46% | 161.11 | 4.00% | |
| BUY | $811.7B | 548.6% | 43.85 | 30.99% | |
| BUY | $450.2B | 30.76% | 17.98 | 27.26% | |
| BUY | $216.2B | 37.75% | 12.53 | 35.61% | |
| BUY | $209.5B | 5.01% | 10.92 | 29.63% |
The Abbvie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abbvie Inc investment value today
Current value as on today
₹1,13,440
Returns
₹13,440
(+13.44%)
Returns from Abbvie Inc Stock
₹8,405 (+8.4%)
Dollar Returns*
₹5,036 (+5.04%)
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for Abbvie Inc. Average target price of $240.39
Get share price movements and forecasts by analysts on Abbvie Inc.
What analysts predicted
9.27%UPSIDE
Target Price
$240.39
Current Price
$218.11
Analyzed by
35 Analysts
Target
$240.39
Abbvie Inc target price $240.39, a slight upside of 9.27% compared to current price of $218.11. According to 35 analysts rating.
Investment in Abbvie Inc Shares on INDmoney has grown by 25.05% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:25.05% versus previous 30 day period
Search interest for Abbvie Inc Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:15% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 November
Mon, 06:51 PM
-Analyst recommends staying long on AbbVie, citing strong year-to-date performance despite broader industry pressures.
Mon, 07:46 PM
-BofA lowers AbbVie price target to $248, maintains Neutral rating amid concerns over stock performance.
Mon, 07:49 PM
-Baron Health Care Fund adds AbbVie to its portfolio, citing strong growth potential in immunology and pipeline expansion.
Today's Timeline - 03 November
Mon, 08:05 PM
-AbbVie exceeds revenue expectations in Q3, driven by immunology and neuroscience growth, but faces margin pressure.
Tue, 05:15 AM
-AbbVie shares climbed 11.8% over six months, driven by strong immunology drug performance despite Humira sales decline.
Tue, 05:49 AM
-AbbVie reports strong Q3 results, raising 2025 outlook despite Humira sales decline and aesthetics challenges.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Abbvie Inc has shown positive revenue growth over the last three quarters. The company's revenue increased from $13.34 billion to $15.77 billion, reflecting an average growth of 7.9% each quarter.
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 159.0% return, outperforming this stock by 109.8%
Against Peers
![]()
In the last 1 year, Eli Lilly And Company has given 19.2% return, outperforming this stock by 11.5%
Profit Down
![]()
Abbvie Inc's net profit has decreased for the last three quarters, dropping from $1.28 billion to $186 million. This represents an average decline of 53.5% each quarter.
Price Dip
![]()
In the last 7 days, ABBV stock has moved down by -5.0%
| Organisation | Abbvie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer |
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Dr. Roopal Thakkar M.D. | Executive VP of Research and Development & Chief Scientific Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Abbvie Inc share price today is $218.11 as on . Abbvie Inc share today touched a day high of $219.68 and a low of $215.65.
Abbvie Inc share touched a 52 week high of $244.81 on and a 52 week low of $163.81 on . Abbvie Inc stock price today i.e. is trending at $218.11,which is 10.91% down from its 52 week high and 33.15% up from its 52 week low.
Abbvie Inc market capitalisation is $0.38T as on .
Indian investors can start investing in Abbvie Inc (ABBV) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Abbvie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abbvie Inc share’s latest price of $218.11 as on November 7, 2025 at 1:39 am IST, you will get 0.0458 shares of Abbvie Inc. Learn more about
fractional shares .
Abbvie Inc stock has given 133.46% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?